The GLU-10: a validated ten-point score to identify poorly instructed celiac patients in need of dietary interventions.


Journal

Minerva gastroenterology
ISSN: 2724-5365
Titre abrégé: Minerva Gastroenterol (Torino)
Pays: Italy
ID NLM: 101777280

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 23 9 2021
medline: 23 3 2022
entrez: 22 9 2021
Statut: ppublish

Résumé

A standard tool to assess patients' knowledge about gluten and the gluten-free diet (GFD) is lacking. We aimed to develop and validate a questionnaire to assess GFD knowledge. A 10-point questionnaire (GLU10) covering different aspects of knowledge about gluten content in food/non-food products and the gluten-free living was developed. To validate this questionnaire, it was administered to adult celiac patients already instructed on gluten and the GFD and non-celiac controls. Patients were prospectively recruited at our Gastroenterology Outpatient Clinic between August 2020 and February 2021. One hundred and six patients (52 celiac patients and 54 controls) participated in the validation phase. Celiac patients scored significantly higher than controls on the GLU10 Questionnaire (median 6 points vs. 2 points, P<0.001). Higher self-reported knowledge of the GFD was related to a higher score (P<0.001). ROC curve confirmed the ability of the GLU10 Questionnaire to discriminate between subjects with good and poor GFD knowledge (AUC=0.94, 95% CI: 0.90-0.98). A score of 5 was identified as the best cut-off (sensitivity 80.8%, specificity 94.4%). On multivariable logistic regression analysis, being a celiac patient (P<0.001) and having a university degree (P=0.04) were associated to a high GLU10 Score (≥5). GLU10 is the first validated questionnaire for assessing knowledge of a GFD in celiac patients and the general population.

Sections du résumé

BACKGROUND BACKGROUND
A standard tool to assess patients' knowledge about gluten and the gluten-free diet (GFD) is lacking.
METHODS METHODS
We aimed to develop and validate a questionnaire to assess GFD knowledge. A 10-point questionnaire (GLU10) covering different aspects of knowledge about gluten content in food/non-food products and the gluten-free living was developed. To validate this questionnaire, it was administered to adult celiac patients already instructed on gluten and the GFD and non-celiac controls. Patients were prospectively recruited at our Gastroenterology Outpatient Clinic between August 2020 and February 2021.
RESULTS RESULTS
One hundred and six patients (52 celiac patients and 54 controls) participated in the validation phase. Celiac patients scored significantly higher than controls on the GLU10 Questionnaire (median 6 points vs. 2 points, P<0.001). Higher self-reported knowledge of the GFD was related to a higher score (P<0.001). ROC curve confirmed the ability of the GLU10 Questionnaire to discriminate between subjects with good and poor GFD knowledge (AUC=0.94, 95% CI: 0.90-0.98). A score of 5 was identified as the best cut-off (sensitivity 80.8%, specificity 94.4%). On multivariable logistic regression analysis, being a celiac patient (P<0.001) and having a university degree (P=0.04) were associated to a high GLU10 Score (≥5).
CONCLUSIONS CONCLUSIONS
GLU10 is the first validated questionnaire for assessing knowledge of a GFD in celiac patients and the general population.

Identifiants

pubmed: 34547859
pii: S2724-5985.21.03037-0
doi: 10.23736/S2724-5985.21.03037-0
doi:

Substances chimiques

Glutens 8002-80-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-97

Auteurs

Marta Vernero (M)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Annalisa Schiepatti (A)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy - annalisa.schiepatti01@universitadipavia.it.

Stiliano Maimaris (S)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Francesca Lusetti (F)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Davide Scalvini (D)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Fabiola Megang (F)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Maria L Nicolardi (ML)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Gian M Gabrielli (GM)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Elisa Sprio (E)

Department of Internal Medicine, Foundation IRCCS Polyclinic San Matteo, Pavia, Italy.

Paola Baiardi (P)

Clinical Scientific Institutes Maugeri IRCCS, Pavia, Italy.

Federico Biagi (F)

Unit of Gastroenterology, Clinical Scientific Institutes Maugeri IRCCS, University of Pavia, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH